Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
‘President of peace’: Trump tapped for Nobel Prize...
Trump’s push for Putin-Zelenskyy talks hinges on Kremlin’s...
Israel eliminates Gaza terrorist who took part in...
White House rejects ‘blank checks’ for Ukraine, presses...
Justice Barrett teases new memoir in abrupt conference...
Schiff launches legal defense fund in response to...
Gabbard removes clearances from 37 officials at Trump’s...
Russia launches largest attack on Ukraine this month...
Trump slams mail-in ballots as corrupt, but may...
I made memes for the White House. Here’s...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Best-performing Canadian Nickel Stocks of 2024
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

You may also like

Coniagas Initiates Global Feed First Strategy on Critical...

September 10, 2024

Heliostar Presents Fourth Quarter 2024 Financial Results

February 28, 2025

Silver Price at New Base, What Comes Next?...

July 15, 2025

Could the Silver Price Really Hit $100 per...

January 3, 2025

SAGA Metals Completes Strategic Infrastructure Upgrades in Preparation...

July 30, 2025

Heliostar CFO Commences Role and Incentive Grant

March 4, 2025

Ukraine Invites Australian Miners to Invest in Resources...

March 7, 2025

BHP: Global Copper Demand to Surge 70 Percent...

October 3, 2024

Should You Invest in Silver Bullion?

June 6, 2025

Noble Announces Results of 2025 Shareholder Meeting

February 28, 2025

Recent Posts

  • ‘President of peace’: Trump tapped for Nobel Prize amid talks to end Russia-Ukraine war
  • Trump’s push for Putin-Zelenskyy talks hinges on Kremlin’s conditions
  • Israel eliminates Gaza terrorist who took part in October attack on kibbutz, took Yarden Bibas hostage
  • White House rejects ‘blank checks’ for Ukraine, presses NATO to shoulder costs
  • Justice Barrett teases new memoir in abrupt conference exit

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (881)
    • Investing (2,793)
    • Politics (3,430)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.